Roche Holding AG plans to test whether an experimental medicine can prevent Alzheimer’s disease symptoms in high-risk people, ...

Swiss drugmaker Roche reported better than expected first-half operating profit on Thursday, driven by strong sales of breast cancer and asthma treatments.

Roche’s Alzheimer’s disease therapy has continued to show benefit for patients after 28 weeks in a long-term extension study.

The drugmaker’s sales were up 7% at constant currency from the same period last year.

One of La Roche-Posay’s hallmark products is its La Roche-Posay Eau Thermal Spring Water, which is a refreshing skincare essential for any time of day, any place.

Roche had bid $91 a share in what it said was its best and final offer. But it would eventually relent and win by bidding $114.50 a share, almost $10 more than its rival, at the end of the day.

Swiss drugmaker Roche Holding plans to investigate whether an experimental medicine can delay or prevent Alzheimer's disease ...